Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NMRA |
---|---|---|
09:32 ET | 3429 | 9.72 |
09:34 ET | 200 | 9.69 |
09:36 ET | 1698 | 9.67 |
09:39 ET | 300 | 9.72 |
09:41 ET | 200 | 9.67 |
09:43 ET | 4024 | 9.81 |
09:45 ET | 300 | 9.85 |
09:48 ET | 1164 | 9.77 |
09:52 ET | 700 | 9.65 |
09:54 ET | 300 | 9.61 |
09:56 ET | 600 | 9.61 |
09:57 ET | 900 | 9.63 |
09:59 ET | 3500 | 9.7 |
10:01 ET | 849 | 9.68 |
10:03 ET | 200 | 9.645 |
10:08 ET | 400 | 9.63 |
10:10 ET | 1000 | 9.635 |
10:12 ET | 5486 | 9.64 |
10:14 ET | 1571 | 9.68 |
10:17 ET | 1350 | 9.66 |
10:19 ET | 1166 | 9.64 |
10:21 ET | 2429 | 9.675 |
10:24 ET | 1300 | 9.65 |
10:28 ET | 2516 | 9.695 |
10:30 ET | 100 | 9.72 |
10:32 ET | 1010 | 9.695 |
10:35 ET | 500 | 9.675 |
10:37 ET | 118 | 9.675 |
10:39 ET | 600 | 9.675 |
10:42 ET | 615 | 9.675 |
10:44 ET | 3550 | 9.72 |
10:46 ET | 1100 | 9.73 |
10:48 ET | 3554 | 9.76 |
10:50 ET | 1300 | 9.79 |
10:51 ET | 737 | 9.775 |
10:53 ET | 1700 | 9.79 |
10:55 ET | 4019 | 9.85 |
10:57 ET | 310 | 9.88 |
11:00 ET | 400 | 9.85 |
11:02 ET | 200 | 9.85 |
11:06 ET | 1033 | 9.88 |
11:08 ET | 1900 | 9.85 |
11:09 ET | 750 | 9.84 |
11:11 ET | 700 | 9.81 |
11:13 ET | 300 | 9.82 |
11:15 ET | 200 | 9.82 |
11:18 ET | 5864 | 9.905 |
11:20 ET | 500 | 9.92 |
11:22 ET | 200 | 9.93 |
11:24 ET | 400 | 9.93 |
11:26 ET | 100 | 9.94 |
11:27 ET | 1100 | 9.94 |
11:29 ET | 3092 | 9.92 |
11:31 ET | 1101 | 9.91 |
11:33 ET | 400 | 9.91 |
11:36 ET | 3689 | 9.94 |
11:38 ET | 1875 | 9.96 |
11:40 ET | 500 | 9.98 |
11:44 ET | 1800 | 10 |
11:45 ET | 5473 | 9.96 |
11:47 ET | 600 | 9.97 |
11:49 ET | 400 | 9.98 |
11:51 ET | 1500 | 9.98 |
11:54 ET | 950 | 9.99 |
11:56 ET | 1300 | 9.96 |
11:58 ET | 600 | 9.94 |
12:02 ET | 1868 | 9.885 |
12:03 ET | 300 | 9.87 |
12:05 ET | 200 | 9.87 |
12:07 ET | 513 | 9.87 |
12:09 ET | 400 | 9.87 |
12:12 ET | 975 | 9.87 |
12:14 ET | 600 | 9.885 |
12:16 ET | 200 | 9.87 |
12:18 ET | 409 | 9.87 |
12:20 ET | 7615 | 9.93 |
12:21 ET | 211 | 9.93 |
12:23 ET | 300 | 9.94 |
12:25 ET | 900 | 9.92 |
12:27 ET | 710 | 9.91 |
12:30 ET | 100 | 9.89 |
12:32 ET | 1007 | 9.885 |
12:34 ET | 1020 | 9.9 |
12:38 ET | 808 | 9.86 |
12:39 ET | 728 | 9.855 |
12:41 ET | 506 | 9.85 |
12:43 ET | 500 | 9.84 |
12:45 ET | 2365 | 9.87 |
12:48 ET | 3415 | 9.845 |
12:50 ET | 128 | 9.84 |
12:52 ET | 513 | 9.83 |
12:54 ET | 100 | 9.83 |
12:57 ET | 1634 | 9.83 |
01:01 ET | 1500 | 9.86 |
01:03 ET | 800 | 9.86 |
01:06 ET | 450 | 9.87 |
01:08 ET | 1100 | 9.87 |
01:10 ET | 6712 | 9.97 |
01:12 ET | 751 | 9.99 |
01:14 ET | 2838 | 10 |
01:15 ET | 200 | 9.99 |
01:19 ET | 14566 | 10 |
01:21 ET | 16967 | 10 |
01:24 ET | 6247 | 10.08 |
01:26 ET | 4739 | 10.15 |
01:28 ET | 74373 | 10.075 |
01:30 ET | 3362 | 10.1 |
01:32 ET | 3502 | 10.13 |
01:33 ET | 2279 | 10.14 |
01:35 ET | 13531 | 10.09 |
01:37 ET | 700 | 10.07 |
01:39 ET | 3154 | 10.17 |
01:42 ET | 6779 | 10.12 |
01:44 ET | 600 | 10.11 |
01:46 ET | 800 | 10.11 |
01:48 ET | 2300 | 10.05 |
01:50 ET | 2722 | 10.055 |
01:51 ET | 5900 | 10.07 |
01:53 ET | 2179 | 10.09 |
01:55 ET | 2100 | 10.05 |
01:57 ET | 100 | 10.04 |
02:00 ET | 500 | 10.04 |
02:02 ET | 1400 | 9.96 |
02:04 ET | 1300 | 9.97 |
02:06 ET | 5113 | 10.05 |
02:08 ET | 904 | 10.06 |
02:09 ET | 1004 | 10.01 |
02:11 ET | 1650 | 10.0133 |
02:13 ET | 1100 | 10.03 |
02:15 ET | 4200 | 10 |
02:18 ET | 1824 | 10.01 |
02:20 ET | 5450 | 10.01 |
02:22 ET | 3722 | 10.05 |
02:24 ET | 1645 | 10.01 |
02:26 ET | 800 | 10 |
02:27 ET | 1449 | 10.02 |
02:29 ET | 492 | 10.02 |
02:31 ET | 6775 | 10.03 |
02:33 ET | 2082 | 10.02 |
02:36 ET | 1550 | 10.04 |
02:38 ET | 430 | 10.03 |
02:40 ET | 600 | 10.02 |
02:42 ET | 2629 | 9.98 |
02:45 ET | 27357 | 9.95 |
02:47 ET | 362 | 9.945 |
02:49 ET | 28317 | 10.01 |
02:51 ET | 1282 | 10.01 |
02:54 ET | 900 | 10.01 |
02:56 ET | 5614 | 10.01 |
02:58 ET | 2230 | 10.01 |
03:00 ET | 100 | 10.01 |
03:02 ET | 1200 | 10.02 |
03:03 ET | 883 | 10.01 |
03:05 ET | 3929 | 10.105 |
03:07 ET | 2150 | 10.08 |
03:09 ET | 1499 | 10.02 |
03:12 ET | 5446 | 10.08 |
03:14 ET | 1770 | 10.05 |
03:16 ET | 500 | 10.06 |
03:18 ET | 1730 | 10.07 |
03:20 ET | 2816 | 10.04 |
03:21 ET | 500 | 10.04 |
03:23 ET | 2916 | 10.04 |
03:25 ET | 200 | 10.04 |
03:27 ET | 671 | 10.04 |
03:30 ET | 1960 | 10.05 |
03:32 ET | 3094 | 10.06 |
03:34 ET | 1100 | 10.05 |
03:36 ET | 8837 | 10.05 |
03:38 ET | 1476 | 10.04 |
03:39 ET | 1254 | 10.045 |
03:41 ET | 5606 | 10.07 |
03:43 ET | 12771 | 10.1 |
03:45 ET | 1504 | 10.11 |
03:48 ET | 3817 | 10.095 |
03:50 ET | 5977 | 10.095 |
03:52 ET | 6796 | 10.14 |
03:54 ET | 11433 | 10.165 |
03:56 ET | 14516 | 10.23 |
03:57 ET | 34169 | 10.24 |
03:59 ET | 56597 | 10.25 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Neumora Therapeutics Inc | 1.6B | -6.6x | --- |
Kura Oncology Inc | 1.5B | -9.2x | --- |
Keros Therapeutics Inc | 1.5B | -8.2x | --- |
Akero Therapeutics Inc | 1.5B | -6.7x | --- |
Morphic Holding Inc | 1.6B | -9.1x | --- |
Soleno Therapeutics Inc | 1.4B | -15.3x | --- |
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 159.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.55 |
Book Value | $2.95 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.